March 6, 2026 · Form 4 insider transaction
Schneyer Mark C. bought 26,382 shares of ACADIA Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.; The restricted stock units vest in four equal annual installments beginning March 6, 2027.